A new trivalent recombinant protein for type 2 diabetes mellitus with oral delivery potential: design, expression, and experimental validation

References

• Agrawal, P., Bhalla, S., Usmani, S. S., Singh, S., Chaudhary, K., Raghava, G. P. S., & Gautam, A. (2016). CPPsite 2.0: A repository of experimentally validated cell-penetrating peptides. Nucleic Acids Research, 44(D1), D1098–D1103. https://doi.org/10.1093/nar/gkv1266
   PubMed Web of Science ®Google Scholar
• Akita, T., Kimura, R., Akaguma, S., Nagai, M., Nakao, Y., Tsugane, M., Suzuki, H., Oka, J.-I., & Yamashita, C. (2021). Usefulness of cell-penetrating peptides and penetration accelerating sequence for nose-to-brain delivery of glucagon-like peptide-2. Journal of Controlled Release: Official Journal of the Controlled Release Society, 335, 575–583. https://doi.org/10.1016/j.jconrel.2021.06.007
   PubMed Web of Science ®Google Scholar
• Amet, N., Lee, H. F., & Shen, W. C. (2009). Insertion of the designed helical linker led to increased expression of tf-based fusion proteins. Pharmaceutical Research, 26(3), 523–528. https://doi.org/10.1007/s11095-008-9767-0
   PubMed Web of Science ®Google Scholar
• Bakker, T., Stumpp, M. T., Binz, H. K., Phillips, Ph., Dolado, I., Forrer, P., Merz, F.W., Sonderegger, I., Steiner, D., Gulotti-Georgieva, M., & Saliba, J. A. (2016). Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains. Google Patents.
   Google Scholar
• Binz, H. K., Binz, H. K., Bakker, T. R., Phillips, D. J., Cornelius, A., Zitt, C., Göttler, T., Sigrist, G., Fiedler, U., Ekawardhani, S., Dolado, I., Saliba, J. A., Tresch, G., Proba, K. & Stumpp, M. T. (2017). Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidate. In MAbs, 9(8), 1262–1269. Taylor & Francis. https://doi.org/10.1080/19420862.2017.1305529
   Google Scholar
• Boersma, Y. L. (2018). Advances in the application of designed ankyrin repeat proteins (DARPins.). Research tools and protein therapeutics, in protein scaffolds. Springer. p. 307–327.
   Google Scholar
• Brayden, D. J., Hill, T. A., Fairlie, D. P., Maher, S., & Mrsny, R. J. (2020). Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches. Advanced Drug Delivery Reviews, 157, 2–36. https://doi.org/10.1016/j.addr.2020.05.007
   PubMed Web of Science ®Google Scholar
• Buccini, D. F., Cardoso, M. H., & Franco, O. L. (2020). Antimicrobial peptides and cell-penetrating peptides for treating intracellular bacterial infections. Frontiers in Cellular and Infection Microbiology, 10, 612931. https://doi.org/10.3389/fcimb.2020.612931
   PubMed Web of Science ®Google Scholar
• Buckley, S. T., Bækdal, T. A., Vegge, A., Maarbjerg, S. J., Pyke, C., Ahnfelt-Rønne, J., Madsen, K. G., Schéele, S. G., Alanentalo, T., Kirk, R. K., Pedersen, B. L., Skyggebjerg, R. B., Benie, A. J., Strauss, H. M., Wahlund, P.-O., Bjerregaard, S., Farkas, E., Fekete, C., Søndergaard, F. L., … Knudsen, L. B. (2018). Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Science Translational Medicine, 10(467), eaar7047. https://doi.org/10.1126/scitranslmed.aar7047
   PubMed Web of Science ®Google Scholar
• Chang, X., Keller, D., O'Donoghue, S. I., & Led, J. J. (2002). NMR studies of the aggregation of glucagon-like peptide-1: Formation of a symmetric helical dimer. FEBS Letters, 515(1-3), 165–170. https://doi.org/10.1016/s0014-5793(02)02466-3
   PubMed Web of Science ®Google Scholar
• Chen, X., Zaro, J. L., & Shen, W.-C. (2013). Fusion protein linkers: Property, design and functionality. Advanced Drug Delivery Reviews, 65(10), 1357–1369. https://doi.org/10.1016/j.addr.2012.09.039
   PubMed Web of Science ®Google Scholar
• Collado Camps, E., van Lith, S. A. M., Kip, A., Frielink, C., Joosten, L., Brock, R., & Gotthardt, M. (2023). Conjugation to a cell-penetrating peptide drives the tumour accumulation of the GLP1R antagonist exendin (9-39). European Journal of Nuclear Medicine and Molecular Imaging, 50(4), 996–1004. https://doi.org/10.1007/s00259-022-06041-y
   PubMed Web of Science ®Google Scholar
• Colovos, C., & Yeates, T. (1993). ERRAT: An empirical atom-based method for validating protein structures. Protein Science: A Publication of the Protein Society, 2(9), 1511–1519. https://doi.org/10.1002/pro.5560020916
   PubMed Web of Science ®Google Scholar
• Combet, C., Blanchet, C., Geourjon, C., & Deléage, G. (2000). NPS@: network protein sequence analysis. Trends in Biochemical Sciences, 25(3), 147–150. https://doi.org/10.1016/s0968-0004(99)01540-6
   PubMed Web of Science ®Google Scholar
• Du, Z., Su, H., Wang, W., Ye, L., Wei, H., Peng, Z., Anishchenko, I., Baker, D., & Yang, J. (2021). The trRosetta server for fast and accurate protein structure prediction. Nature Protocols, 16(12), 5634–5651. https://doi.org/10.1038/s41596-021-00628-9
   PubMed Web of Science ®Google Scholar
• Ehsasatvatan, M., & Baghban Kohnehrouz, B. (2023). Designing and computational analyzing of chimeric long-lasting GLP-1 receptor agonists for type 2 diabetes. Scientific Reports, 13(1), 17778. https://doi.org/10.1038/s41598-023-45185-1
   PubMed Web of Science ®Google Scholar
• Ehsasatvatan, M., & Kohnehrouz, B. (2023). Effect of Linker’s Length and Sequence on the Structure and Stability of mGLP-1-DARPin Fusion Protein for Treatment of Type 2 Diabetes: A Computational Study. Yafteh Lorestan University of Medical Sciences, 25(2), 26–47. https://doi.org/10.32592/Yafteh.2023.25.2.26
   Google Scholar
• Ehsasatvatan, M., Kohnehrouz, B. B., Gholizadeh, A., Ofoghi, H., & Shanehbandi, D. (2022). The production of the first functional antibody mimetic in higher plants: The chloroplast makes the DARPin G3 for HER2 imaging in oncology. Biological Research, 55(1), 32. https://doi.org/10.1186/s40659-022-00400-7
   PubMed Web of Science ®Google Scholar
• Frejd, F. Y., & Kim, K.-T. (2017). Affibody molecules as engineered protein drugs. Experimental & Molecular Medicine, 49(3), e306-e306–e306. https://doi.org/10.1038/emm.2017.35
   Google Scholar
• Gasteiger, E., Hoogland, Ch., Gattiker, A., Duvaud, S., Wilkins, M., Appel, R. D., & Bairoch, A. (2005). Protein identification and analysis tools on the ExPASy server. The Proteomics Protocols Handbook, 112, 571–607.
   Google Scholar
• Gautam, A., Singh, H., Tyagi, A., Chaudhary, K., Kumar, R., Kapoor, P., & Raghava, G. P. S. (2012). CPPsite: A curated database of cell penetrating peptides. Database: The Journal of Biological Databases and Curation, 2012(0), bas015–bas015. https://doi.org/10.1093/database/bas015
   PubMedGoogle Scholar
• Goldstein, R., Sosabowski, J., Livanos, M., Leyton, J., Vigor, K., Bhavsar, G., Nagy-Davidescu, G., Rashid, M., Miranda, E., Yeung, J., Tolner, B., Plückthun, A., Mather, S., Meyer, T., & Chester, K. (2015). Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging. European Journal of Nuclear Medicine and Molecular Imaging, 42(2), 288–301. https://doi.org/10.1007/s00259-014-2940-2
   PubMed Web of Science ®Google Scholar
• Graaf, C. D., Donnelly, D., Wootten, D., Lau, J., Sexton, P. M., Miller, L. J., Ahn, J.-M., Liao, J., Fletcher, M. M., Yang, D., Brown, A. J. H., Zhou, C., Deng, J., & Wang, M.-W. (2016). Glucagon-like peptide-1 and its class BG protein–coupled receptors: A long march to therapeutic successes. Pharmacological Reviews, 68(4), 954–1013. https://doi.org/10.1124/pr.115.011395
   PubMed Web of Science ®Google Scholar
• Griffith, D. A., Edmonds, D. J., Fortin, J.-P., Kalgutkar, A. S., Kuzmiski, J. B., Loria, P. M., Saxena, A. R., Bagley, S. W., Buckeridge, C., Curto, J. M., Derksen, D. R., Dias, J. M., Griffor, M. C., Han, S., Jackson, V. M., Landis, M. S., Lettiere, D., Limberakis, C., Liu, Y., … Tess, D. A. (2022). A small-molecule oral agonist of the human glucagon-like peptide-1 receptor. Journal of Medicinal Chemistry, 65(12), 8208–8226. https://doi.org/10.1021/acs.jmedchem.1c01856
   PubMed Web of Science ®Google Scholar
• Grote, A., Hiller, K., Scheer, M., Münch, R., Nörtemann, B., Hempel, D. C., & Jahn, D. (2005). JCat: A novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Research, 33(Web Server issue), W526–31. https://doi.org/10.1093/nar/gki376
   PubMed Web of Science ®Google Scholar
• Guo, Z., Peng, H., Kang, J., & Sun, D. (2016). Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications. Biomedical Reports, 4(5), 528–534. https://doi.org/10.3892/br.2016.639
   PubMed Web of Science ®Google Scholar
• Hamman, J. H., Enslin, G. M., & Kotzé, A. F. (2005). Oral delivery of peptide drugs: Barriers and developments. BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 19(3), 165–177. https://doi.org/10.2165/00063030-200519030-00003
   PubMed Web of Science ®Google Scholar
• Han, X., Lu, Y., Xie, J., Zhang, E., Zhu, H., Du, H., Wang, K., Song, B., Yang, C., Shi, Y., & Cao, Z. (2020). Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions. Nature Nanotechnology, 15(7), 605–614. https://doi.org/10.1038/s41565-020-0693-6
   PubMed Web of Science ®Google Scholar
• Hansen, B. B., Nuhoho, S., Ali, S. N., Dang-Tan, T., Valentine, W. J., Malkin, S. J. P., & Hunt, B. (2020). Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: A cost of control analysis. Journal of Medical Economics, 23(6), 650–658. https://doi.org/10.1080/13696998.2020.1722678
   PubMed Web of Science ®Google Scholar
• Hebditch, M., Carballo-Amador, M. A., Charonis, S., Curtis, R., & Warwicker, J. (2017). Protein–Sol: A web tool for predicting protein solubility from sequence. Bioinformatics (Oxford, England), 33(19), 3098–3100. https://doi.org/10.1093/bioinformatics/btx345
   PubMed Web of Science ®Google Scholar
• Holz, G. G., Leech, C. A., & Habener, J. F. (1995). Activation of a cAMP-regulated Ca2+-Signaling Pathway in Pancreatic β-Cells by the insulinotropic hormone glucagon-like peptide-1. The Journal of Biological Chemistry, 270(30), 17749–17757. https://doi.org/10.1074/jbc.270.30.17749
   PubMed Web of Science ®Google Scholar
• Hou, J., Yan, R., Ding, D., Yang, L., Wang, C., Wu, Z., Yu, X., Li, W., & Li, M. (2007). Oral administration of a fusion protein containing eight GLP-1 analogues produced in Escherichia coli BL21 (DE3) in streptozotocin-induced diabetic rats. Biotechnology Letters, 29(10), 1439–1446. https://doi.org/10.1007/s10529-007-9427-1
   PubMed Web of Science ®Google Scholar
• Hughes, S., & Neumiller, J. J. (2020). Oral semaglutide. Clinical Diabetes: A Publication of the American Diabetes Association, 38(1), 109–111. https://doi.org/10.2337/cd19-0079
   PubMedGoogle Scholar
• Interlandi, G., Wetzel, S. K., Settanni, G., Plückthun, A., & Caflisch, A. (2008). Characterization and further stabilization of designed ankyrin repeat proteins by combining molecular dynamics simulations and experiments. Journal of Molecular Biology, 375(3), 837–854. https://doi.org/10.1016/j.jmb.2007.09.042
   PubMed Web of Science ®Google Scholar
• Jiang, T., Olson, E. S., Nguyen, Q. T., Roy, M., Jennings, P. A., & Tsien, R. Y. (2004). Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proceedings of the National Academy of Sciences of the United States of America, 101(51), 17867–17872. https://doi.org/10.1073/pnas.0408191101
   PubMed Web of Science ®Google Scholar
• Jonsson, A., Dogan, J., Herne, N., Abrahmsén, L., & Nygren, P.-A. (2008). Engineering of a femtomolar affinity binding protein to human serum albumin. Protein Engineering, Design & Selection: PEDS, 21(8), 515–527. https://doi.org/10.1093/protein/gzn028
   PubMed Web of Science ®Google Scholar
• Klein, J. S., Jiang, S., Galimidi, R. P., Keeffe, J. R., & Bjorkman, P. J. (2014). Design and characterization of structured protein linkers with differing flexibilities. Protein Engineering, Design & Selection: PEDS, 27(10), 325–330. https://doi.org/10.1093/protein/gzu043
   PubMed Web of Science ®Google Scholar
• Knudsen, L. B., & Lau, J. (2019). The discovery and development of liraglutide and semaglutide. Frontiers in Endocrinology, 10, 155. https://doi.org/10.3389/fendo.2019.00155
   PubMed Web of Science ®Google Scholar
• Kontermann, R. E. (2016). Half-life extended biotherapeutics. Expert Opinion on Biological Therapy, 16(7), 903–915. https://doi.org/10.1517/14712598.2016.1165661
   PubMed Web of Science ®Google Scholar
• Kozakov, D., Hall, D. R., Xia, B., Porter, K. A., Padhorny, D., Yueh, C., Beglov, D., & Vajda, S. (2017). The ClusPro web server for protein-protein docking. Nature Protocols, 12(2), 255–278. https://doi.org/10.1038/nprot.2016.169
   PubMed Web of Science ®Google Scholar
• Kristensen, M., & Nielsen, H. M. (2016). Cell‐penetrating peptides as carriers for oral delivery of biopharmaceuticals. Basic & Clinical Pharmacology & Toxicology, 118(2), 99–106. https://doi.org/10.1111/bcpt.12515
   PubMed Web of Science ®Google Scholar
• Kristensen, M., Franzyk, H., Klausen, M. T., Iversen, A., Bahnsen, J. S., Skyggebjerg, R. B., Foderà, V., & Nielsen, H. M. (2015). Penetratin-mediated transepithelial insulin permeation: Importance of cationic residues and pH for complexation and permeation. The AAPS Journal, 17(5), 1200–1209. https://doi.org/10.1208/s12248-015-9747-3
   PubMed Web of Science ®Google Scholar
• Kumar S, U., Varghese, R. P., Preethi, V. A., Doss, C. G. P., & Zayed, H. (2023). Identification of potential inhibitors targeting GTPase-kirsten RAt sarcoma virus (K-Ras) driven cancers via E-pharmacophore-based virtual screening and drug repurposing approach. Frontiers in Bioscience (Landmark Edition), 28(11), 288. https://doi.org/10.31083/j.fbl2811288
   PubMed Web of Science ®Google Scholar
• Kumar, S. U., et al. (2020). Comprehensive in silico screening and molecular dynamics studies of missense mutations in Sjogren-Larsson syndrome associated with the ALDH3A2 gene. Advances in Protein Chemistry and Structural Biology, 120, 349–377.
   PubMed Web of Science ®Google Scholar
• Kumar, S. U., Sankar, S., Kumar, D. T., Younes, S., Younes, N., Siva, R., Doss, C. G. P., & Zayed, H. (2021). Molecular dynamics, residue network analysis, and cross-correlation matrix to characterize the deleterious missense mutations in GALE causing galactosemia III. Cell Biochemistry and Biophysics, 79(2), 201–219. https://doi.org/10.1007/s12013-020-00960-z
   PubMed Web of Science ®Google Scholar
• Kwon, K.-C., Nityanandam, R., New, J. S., & Daniell, H. (2013). Oral delivery of bioencapsulated exendin‐4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta‐TC 6 cells. Plant Biotechnology Journal, 11(1), 77–86. https://doi.org/10.1111/pbi.12008
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., Jabłońska, J., Pravda, L., Vařeková, R. S., & Thornton, J. M. (2018). PDBsum: Structural summaries of PDB entries. Protein Science: A Publication of the Protein Society, 27(1), 129–134. https://doi.org/10.1002/pro.3289
   PubMed Web of Science ®Google Scholar
• Laskowski, R., MacArthur, M., & Thornton, J. (2006). PROCHECK: Validation of protein-structure coordinates.
   Google Scholar
• Lorenz, R., Bernhart, S. H., Höner Zu Siederdissen, C., Tafer, H., Flamm, C., Stadler, P. F., & Hofacker, I. L. (2013). ViennaRNA package 2.0. Algorithms for Molecular Biology: AMB, 6(1), 26–26. vol, https://doi.org/10.1186/1748-7188-6-26
   Google Scholar
• Marín-Peñalver, J. J., Martín-Timón, I., Sevillano-Collantes, C., & Del Cañizo-Gómez, F. J. (2016). Update on the treatment of type 2 diabetes mellitus. World Journal of Diabetes, 7(17), 354–395. https://doi.org/10.4239/wjd.v7.i17.354
   PubMed Web of Science ®Google Scholar
• McWilliam, H., Li, W., Uludag, M., Squizzato, S., Park, Y. M., Buso, N., Cowley, A. P., & Lopez, R. (2013). Analysis tool web services from the EMBL-EBI. Nucleic Acids Research, 41(Web Server issue), W597–W600. https://doi.org/10.1093/nar/gkt376
   PubMedGoogle Scholar
• Milletti, F. (2012). Cell-penetrating peptides: Classes, origin, and current landscape. Drug Discovery Today, 17(15-16), 850–860. https://doi.org/10.1016/j.drudis.2012.03.002
   PubMed Web of Science ®Google Scholar
• Mótyán, J. A., Tóth, F., & Tőzsér, J. (2013). Research applications of proteolytic enzymes in molecular biology. Biomolecules, 3(4), 923–942. https://doi.org/10.3390/biom3040923
   PubMedGoogle Scholar
• Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., Holst, J. J., Langhans, W., Meier, J. J., Nauck, M. A., Perez-Tilve, D., Pocai, A., Reimann, F., Sandoval, D. A., Schwartz, T. W., … Tschöp, M. H. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism, 30, 72–130. https://doi.org/10.1016/j.molmet.2019.09.010
   PubMed Web of Science ®Google Scholar
• Nielsen, E. J. B., Yoshida, S., Kamei, N., Iwamae, R., Khafagy, E.-S., Olsen, J., Rahbek, U. L., Pedersen, B. L., Takayama, K., & Takeda-Morishita, M. (2014). In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin. Journal of Controlled Release: Official Journal of the Controlled Release Society, 189, 19–24. https://doi.org/10.1016/j.jconrel.2014.06.022
   PubMed Web of Science ®Google Scholar
• Pan, X., Zuallaert, J., Wang, X., Shen, H.-B., Campos, E. P., Marushchak, D. O., & De Neve, W. (2021). ToxDL: Deep learning using primary structure and domain embeddings for assessing protein toxicity. Bioinformatics (Oxford, England), 36(21), 5159–5168. https://doi.org/10.1093/bioinformatics/btaa656
   PubMed Web of Science ®Google Scholar
• Pechenov, S., Revell, J., Will, S., Naylor, J., Tyagi, P., Patel, C., Liang, L., Tseng, L., Huang, Y., Rosenbaum, A. I., Balic, K., Konkar, A., Grimsby, J., & Subramony, J. A. (2021). Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease. Scientific Reports, 11(1), 22521. https://doi.org/10.1038/s41598-021-01750-0
   PubMed Web of Science ®Google Scholar
• Peters, T. Jr., (1985). Serum albumin. Advances in Protein Chemistry, 37, 161–245. https://doi.org/10.1016/s0065-3233(08)60065-0
   PubMedGoogle Scholar
• R, H. C., Kumar S, U., R, G., Naayanan, P. J., Sathiyarajeswaren, P., Devi, M. S. S., K, S. S., & Doss C, G. P. (2023). An integrated investigation of structural and pathway alteration caused by PIK3CA and TP53 mutations identified in cfDNA of metastatic breast cancer. Journal of Cellular Biochemistry, 124(2), 188–204. https://doi.org/10.1002/jcb.30354
   PubMed Web of Science ®Google Scholar
• Reed, J., Bain, S., & Kanamarlapudi, V. (2020). Recent advances in understanding the role of glucagon-like peptide 1. F1000Research, 9, 239. https://doi.org/10.12688/f1000research.20602.1
   Google Scholar
• Ren, L., Cui, Q., Liu, W., Wang, L., Liao, Y., Feng, Y., Sun, W., Yang, Y., Zhang, Z., Jin, T., Prud’homme, G. J., Zhang, L., Li, Y., Leng, Y., & Wang, Q. (2019). Novel GLP-1 analog supaglutide stimulates insulin secretion in mouse and human islet beta-cells and improves glucose homeostasis in diabetic mice. Frontiers in Physiology, 10, 930. https://doi.org/10.3389/fphys.2019.00930
   PubMed Web of Science ®Google Scholar
• Rizzuti, M., Nizzardo, M., Zanetta, C., Ramirez, A., & Corti, S. (2015). Therapeutic applications of the cell-penetrating HIV-1 Tat peptide. Drug Discovery Today, 20(1), 76–85. https://doi.org/10.1016/j.drudis.2014.09.017
   PubMed Web of Science ®Google Scholar
• Sadeghian, I., Heidari, R., Sadeghian, S., Raee, M. J., & Negahdaripour, M. (2022). Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences, 169, 106094. https://doi.org/10.1016/j.ejps.2021.106094
   PubMed Web of Science ®Google Scholar
• Saraiva, J. F. K., & Franco, D. (2021). Oral GLP-1 analogue: Perspectives and impact on atherosclerosis in type 2 diabetic patients. Cardiovascular Diabetology, 20(1), 235. https://doi.org/10.1186/s12933-021-01417-0
   PubMed Web of Science ®Google Scholar
• Saxena, A. R., Gorman, D. N., Esquejo, R. M., Bergman, A., Chidsey, K., Buckeridge, C., Griffith, D. A., & Kim, A. M. (2021). Danuglipron (PF-06882961) in type 2 diabetes: A randomized, placebo-controlled, multiple ascending-dose phase 1 trial. Nature Medicine, 27(6), 1079–1087. https://doi.org/10.1038/s41591-021-01391-w
   PubMed Web of Science ®Google Scholar
• Shah, R. B., Ahsan, F., & Khan, M. A. (2002). Oral delivery of proteins: Progress and prognostication. Critical Reviews™ in Therapeutic Drug Carrier Systems, 19(2), 135–169.
   PubMed Web of Science ®Google Scholar
• Shilova, O., & Deyev, S. (2019). DARPins: Promising scaffolds for theranostics. Acta Naturae (англоязычная версия), 11(4), 42–53. https://doi.org/10.32607/20758251-2019-11-4-42-53
   PubMed Web of Science ®Google Scholar
• Siegel, P. M., Bojti, I., Bassler, N., Holien, J., Flierl, U., Wang, X., Waggershauser, P., Tonnar, X., Vedecnik, C., Lamprecht, C., Stankova, I., Li, T., Helbing, T., Wolf, D., Anto-Michel, N., Mitre, L. S., Ehrlich, J., Orlean, L., Bender, I., … Diehl, P. (2021). A DARPin targeting activated Mac-1 is a novel diagnostic tool and potential anti-inflammatory agent in myocarditis, sepsis and myocardial infarction. Basic Research in Cardiology, 116(1), 17. https://doi.org/10.1007/s00395-021-00849-9
   PubMed Web of Science ®Google Scholar
• Steeland, S., Vandenbroucke, R. E., & Libert, C. (2016). Nanobodies as therapeutics: Big opportunities for small antibodies. Drug Discovery Today, 21(7), 1076–1113. https://doi.org/10.1016/j.drudis.2016.04.003
   PubMed Web of Science ®Google Scholar
• Steffansen, B., Nielsen, C. U., & Frokjaer, S. (2005). Delivery aspects of small peptides and substrates for peptide transporters. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V, 60(2), 241–245. https://doi.org/10.1016/j.ejpb.2005.01.004
   PubMed Web of Science ®Google Scholar
• Steiner, D., Merz, F. W., Sonderegger, I., Gulotti-Georgieva, M., Villemagne, D., Phillips, D. J., Forrer, P., Stumpp, M. T., Zitt, C., & Binz, H. K. (2017). Half-life extension using serum albumin-binding DARPin® domains. Protein Engineering, Design & Selection: PEDS, 30(9), 583–591. https://doi.org/10.1093/protein/gzx022
   PubMed Web of Science ®Google Scholar
• Strohl, W. R. (2015). Fusion proteins for half-life extension of biologics as a strategy to make biobetters. BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 29(4), 215–239. https://doi.org/10.1007/s40259-015-0133-6
   PubMed Web of Science ®Google Scholar
• Stumpp, M. T., Dawson, K. M., & Binz, H. K. (2020). Beyond Antibodies: The DARPin(®) Drug Platform. BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 34(4), 423–433. https://doi.org/10.1007/s40259-020-00429-8
   PubMed Web of Science ®Google Scholar
• Sugita, T., Yoshikawa, T., Mukai, Y., Yamanada, N., Imai, S., Nagano, K., Yoshida, Y., Shibata, H., Yoshioka, Y., Nakagawa, S., Kamada, H., Tsunoda, S-I., & Tsutsumi, Y. (2007). Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide. Biochemical and Biophysical Research Communications, 363(4), 1027–1032. https://doi.org/10.1016/j.bbrc.2007.09.077
   PubMed Web of Science ®Google Scholar
• Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., Stein, C., Basit, A., Chan, J. C. N., Mbanya, J. C., Pavkov, M. E., Ramachandaran, A., Wild, S. H., James, S., Herman, W. H., Zhang, P., Bommer, C., Kuo, S., Boyko, E. J., & Magliano, D. J. (2022). IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice, 183, 109119. https://doi.org/10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• Tayubi, I. A., Kumar, S. U., & Doss, C. G. (2022). Identification of potential inhibitors, conformational dynamics, and mechanistic insights into mutant Kirsten rat sarcoma virus (G13D) driven cancers. Journal of Cellular Biochemistry, 123(9), 1467–1480. https://doi.org/10.1002/jcb.30305
   PubMed Web of Science ®Google Scholar
• Underwood, C. R., Garibay, P., Knudsen, L. B., Hastrup, S., Peters, G. H., Rudolph, R., & Reedtz-Runge, S. (2010). Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor. The Journal of Biological Chemistry, 285(1), 723–730. https://doi.org/10.1074/jbc.M109.033829
   PubMed Web of Science ®Google Scholar
• Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. C. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26(16), 1701–1718. https://doi.org/10.1002/jcc.20291
   PubMed Web of Science ®Google Scholar
• Van Roy, M., Ververken, C., Beirnaert, E., Hoefman, S., Kolkman, J., Vierboom, M., Breedveld, E., 't Hart, B., Poelmans, S., Bontinck, L., Hemeryck, A., Jacobs, S., Baumeister, J., & Ulrichts, H. (2015). The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis. Arthritis Research & Therapy, 17(1), 135. https://doi.org/10.1186/s13075-015-0651-0
   PubMedGoogle Scholar
• Wang, Y., Dilidaxi, D., Wu, Y., Sailike, J., Sun, X., & Nabi, X.-H. (2020). Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 125, 109914. https://doi.org/10.1016/j.biopha.2020.109914
   PubMed Web of Science ®Google Scholar
• Wiederstein, M., & Sippl, M. J. (2007). ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research, 35(Web Server issue), W407–10. https://doi.org/10.1093/nar/gkm290
   PubMed Web of Science ®Google Scholar
• Xia, J., Gao, G., Zhang, C., Ying, J., & Li, J. (2023). Albumin-binding DARPins as scaffold improve the hypoglycemic and anti-obesity effects of exendin-4 in vivo. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences, 185, 106422. https://doi.org/10.1016/j.ejps.2023.106422
   PubMed Web of Science ®Google Scholar
• Xiao, Q., Giguere, J., Parisien, M., Jeng, W., St-Pierre, S. A., Brubaker, P. L., & Wheeler, M. B. (2001). Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo. Biochemistry, 40(9), 2860–2869. https://doi.org/10.1021/bi0014498
   PubMed Web of Science ®Google Scholar
• Xie, J., Bi, Y., Zhang, H., Dong, S., Teng, L., Lee, R. J., & Yang, Z. (2020). Cell-penetrating peptides in diagnosis and treatment of human diseases: From preclinical research to clinical application. Frontiers in Pharmacology, 11, 697. https://doi.org/10.3389/fphar.2020.00697
   PubMed Web of Science ®Google Scholar
• Xu, F., Wang, K. Y., Wang, N., Li, G., & Liu, D. (2017). Modified human glucagon-like peptide-1 (GLP-1) produced in E. coli has a long-acting therapeutic effect in type 2 diabetic mice. PloS One, 12(7), e0181939. https://doi.org/10.1371/journal.pone.0181939
   PubMed Web of Science ®Google Scholar
• Xue, L. C., Rodrigues, J. P., Kastritis, P. L., Bonvin, A. M., & Vangone, A. (2016). PRODIGY: A web server for predicting the binding affinity of protein-protein complexes. Bioinformatics (Oxford, England), 32(23), 3676–3678. https://doi.org/10.1093/bioinformatics/btw514
   PubMed Web of Science ®Google Scholar
• Zahnd, C., Kawe, M., Stumpp, M. T., de Pasquale, C., Tamaskovic, R., Nagy-Davidescu, G., Dreier, B., Schibli, R., Binz, H. K., Waibel, R., & Plückthun, A. (2010). Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: Effects of affinity and molecular size. Cancer Research, 70(4), 1595–1605. https://doi.org/10.1158/0008-5472.CAN-09-2724
   PubMed Web of Science ®Google Scholar
• Zahnd, C., Wyler, E., Schwenk, J. M., Steiner, D., Lawrence, M. C., McKern, N. M., Pecorari, F., Ward, C. W., Joos, T. O., & Plückthun, A. (2007). A designed ankyrin repeat protein evolved to picomolar affinity to Her2. Journal of Molecular Biology, 369(4), 1015–1028. https://doi.org/10.1016/j.jmb.2007.03.028
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Guo, P., Ma, Z., Lu, P., Kebebe, D., & Liu, Z. (2021). Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: A review. Journal of Nanobiotechnology, 19(1), 255. https://doi.org/10.1186/s12951-021-01002-3
   PubMed Web of Science ®Google Scholar
• Zuker, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Research, 31(13), 3406–3415. https://doi.org/10.1093/nar/gkg595
   PubMed Web of Science ®Google Scholar